Cansortium has begun growing in Phase 2 at its state-of-the-art indoor medical marijuana cultivation facility in Tampa, Florida.
Cansortium Chief Executive Officer Jose Hidalgo emphasized, "Expanding our Florida production capacity provides us with additional supply of high-quality cannabis to process into the wide variety of Fluent-branded medical marijuana products sold through our Florida dispensary network. In addition to our exciting progress in Florida, we continue to build our business platforms in Texas, Pennsylvania, and Puerto Rico, as well as pursue foundational licensing in other markets to support future growth."
"Approved by the Florida Department of Health on August 6, 2019, Phase 2 will enable the company to realize an effective canopy coverage which, when fully propagated, will more than double the Company's existing production capability." Previously an indoor vertical lettuce farm, the Tampa cultivation facility utilizes a state-of-the-art multi-level vertical cultivation method which, according to them, enables the Company to produce a total cultivation canopy area equivalent to a 60,000 square foot greenhouse in only a 21,000 square foot footprint. The company expects the first harvest from its new Phase 2 Tampa facility to occur in October 2019, with subsequent ongoing harvests anticipated to mature approximately every week once the facility is fully propagated.
In addition to the Company's Tampa cultivation facility, the company operates a 31,000 square-foot greenhouse and GMP-certified 9,000 square-foot processing facility in Winter Garden, Florida. Together, the Company's Tampa and Winter Garden facilities are expected to supply the raw materials needed to produce the Company's full assortment of Fluent-branded medical marijuana products for the Florida market, including dried flower.
For more information:
Cansortium Inc.
82 NE 26th Street, Miami, Florida 33137
+1 (305) 902-2720
investors@cansortium.com
cansortium.com